Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04331067
Title Cabiralizumab in Combination With Nivolumab and Neoadjuvant Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

triple-receptor negative breast cancer

Therapies

Cabiralizumab + Carboplatin + Nivolumab + Paclitaxel

Carboplatin + Nivolumab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field